Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
13.2M
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
21.5K
-
Shares change
-
-29.2K
-
Total reported value, excl. options
-
$72.3K
-
Value change
-
-$187K
-
Number of buys
-
5
-
Number of sells
-
-3
-
Price
-
$3.37
Significant Holders of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) as of Q4 2022
8 filings reported holding SILO - Silo Pharma, Inc. - Common stock, par value $0.0001 per share as of Q4 2022.
Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.5K shares
of 13.2M outstanding shares and own 0.16% of the company stock.
Largest 8 shareholders include Financial Advocates Investment Management (15K shares), UBS Group AG (5.21K shares), Tower Research Capital LLC (TRC) (1.16K shares), FWL INVESTMENT MANAGEMENT, LLC (80 shares), WELLS FARGO & COMPANY/MN (19 shares), MORGAN STANLEY (5 shares), Shay Capital LLC (0 shares), and FNY Investment Advisers, LLC (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.